Private Equity

A new partnership aims to fill a crucial funding gap for mid-sized businesses with flexible capital, backed by veterans from Oaktree, Sixth Street, and Apollo.

The advisory giant's acquisition of a Boston-based specialist signals a strategic push into the high-stakes, high-growth world of life sciences and biotech.

With its IPO complete, Cambridge Acquisition Corp. enters a disciplined SPAC market with a clear focus on wellness, hemp, and psychedelic tech targets.

Inside the TIGER 21 summit where the world’s ultra-rich strategize on AI, global instability, and the $83 trillion wealth transfer.

An exclusive, invite-only conference in NYC highlights the explosive growth and strategic importance of GP stakes, gathering the industry's elite players.

Arlington Dermatology Clinic joins a national network, highlighting a major trend in healthcare consolidation. What does this mean for DFW patients?

In a strategic move, American Beacon Partners names a new product head to navigate a complex market and deliver next-generation solutions for financial advisors.

Waters finalized its $18.8B merger with BD's units, doubling its size. But investor concerns over near-term performance sent shares tumbling.

Cupani Metals raises over $1.6 million for its Quebec exploration project, a move backed by significant insider investment and a new strategic focus.

With its lead drug in Phase 3, Celldex will update investors at three major conferences, highlighting its immunology pipeline and financial strategy.

As it marks its 40th year, the legal finance giant's impressive 3.0x return on capital highlights the growing appeal of legal assets as a stable asset class.

With five conferences in its sights, Voyager Therapeutics is making a major push to win over investors ahead of a pivotal year for its neurological pipeline.

Leading manufacturer GEVORKYAN is launching its first ESOP, a strategic move to retain key talent and drive growth in the competitive powder metallurgy market.

Cantor Fitzgerald launches its 15th SPAC, raising $115M. With the market rebounding, will this bet on tech and healthcare pay off for investors?

The veteran SPAC sponsor closes an upsized IPO for its eighth fund, targeting industrial tech and energy transition with a unique warrant-free structure.

Freya Investissement is boosting its economic stake in Tele2 to 27% via swaps, signaling a major consolidation of power by its influential backer, Xavier Niel.

As the AI gold rush intensifies, Futurum Equities hires Rolf Bulk to lead a new semiconductor research arm, promising deeper technical insights for all investors.

The high-tech wheel maker's stock plummets 65% as it fails to meet listing rules, signaling deep financial and operational distress for the company.

Strong investor demand boosts financing for BC's Golden Triangle exploration, highlighting Canada's strategic push into the critical minerals sector.

Tangerine’s socially responsible funds nabbed three prestigious FundGrade A+® Awards, showing investors can align their portfolio with their values without sacrificing performance.